Last update 01 Nov 2024

AstraZeneca Korea Ltd.

Subsidiary Company|
1992|
South Korea
|
www.astrazeneca.co.kr

Overview

Tags

Other Diseases
Hemic and Lymphatic Diseases
Endocrinology and Metabolic Disease
Monoclonal antibody
Small molecule drug
Fusion protein

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases6
Endocrinology and Metabolic Disease5
Immune System Diseases4
Infectious Diseases4
Neoplasms4
Nervous System Diseases3
Top 5 Drug TypeCount
Monoclonal antibody5
Small molecule drug2
Fusion protein1
Enzyme1
Top 5 TargetCount
C5(Complement C5)2
Alkaline phosphatase1
CTLA4(Cytotoxic T-Lymphocyte-Associated Antigen 4)1
LIPA(lipase A, lysosomal acid type)1
RSV F protein(Respiratory syncytial virus F protein)1

Related

9
Drugs associated with AstraZeneca Korea Ltd.
Danicopan
Target
CFD
Mechanism
CFD inhibitors
Active Org.
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc. [+4]
Originator Org.
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc.
Active Indication
Hemoglobinuria, Paroxysmal [+3]
Inactive Indication
C3 glomerulopathy [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date18 Jan 2024
Capivasertib
Target
Akt-1 x Akt-2 x Akt-3
Mechanism
Akt-1 inhibitors [+2]
Active Org.
AstraZeneca Pharmaceuticals LP [+12]
Originator Org.
AstraZeneca PLCAstraZeneca PLC
Active Indication
ER-positive/HER2-negative Breast Cancer [+21]
Inactive Indication
Advanced cancer [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date16 Nov 2023
Nirsevimab
Target
RSV F protein
Mechanism
Respiratory syncytial virus F protein inhibitors
Active Org.
AstraZeneca PLCAstraZeneca PLC [+8]
Originator Org.
AstraZeneca AB
Active Indication
Respiratory Syncytial Virus Infections [+3]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date31 Oct 2022
1
Clinical Trials associated with AstraZeneca Korea Ltd.
KCT0000401 / Not yet recruitingPhase 2
A Phase IIa Multi-centre Randomised Double-Blind Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of AZD8931 in Combination with Paclitaxel versus Paclitaxel alone in Patients with Metastatic, Gastric or Gastro-oesophageal Junction, Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status (SAGE)
100 Clinical Results associated with AstraZeneca Korea Ltd.
Login to view more data
0 Patents (Medical) associated with AstraZeneca Korea Ltd.
Login to view more data
100 Deals associated with AstraZeneca Korea Ltd.
Login to view more data
100 Translational Medicine associated with AstraZeneca Korea Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
9
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free